Verum has been the first Western-
Standard CRO specializing in CEE
countries, operations starting in 1992.
As first registered CRO in various
CEE countries relationships to Investigators and Authorities are
excellent.

More than 120 trials with some
35.000 patients have been completed.
The maximum number of sites handled
by Verum in a single project was 127,
number of patients 1400.

Long-standing relationship and repeat business with leading Pharmaceutical Companies enabled controlled development of the company.

Verum´s core business and key
competence is Full Clinical Service
for Phase II to IV in CEE countries.

With extending our service to South America and Asia we have now
transferred our experience from the
last 20 years to other continents.

Verum has it´s own training company
and puts importance to training and
education. All staff is fixed employed.

Verum has been selected by the
US MoH (NIH/NINDS) to run a
Government funded trial in Europe.